Longterm contraception by subcutaneous silasticR capsules containing megestrol acetate
Authors:
- Elsimar M. CoutinhoECElsimar M. Coutinho
- Carlos E.R. MattosCMCarlos E.R. Mattos
- Ana Rita S. Sant'AnnaASAna Rita S. Sant'Anna
- J. Adeodato FilhoJFJ. Adeodato Filho
- Maria Conceicão SilvaMSMaria Conceicão Silva
- Howard J. TatumHTHoward J. Tatum
- 30 November 1970
- journal article
- Published by Elsevier in Contraception
- Vol. 2 (5) , 313-321
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- EXCRETION OF [6-14C]MEGESTROL ACETATE (6 METHYL-17 ACETOXYPREGNA-4,6 DIENE, 3,20 DIONE) RELEASED FROM SUBCUTANEOUS SILASTIC IMPLANTS IN WOMENReproduction, 1970
- Use of subcutaneous Silastic capsules for long-term steroid contraceptionAmerican Journal of Obstetrics and Gynecology, 1970
- Fertility control in women with a progestogen released in microquantities from subcutaneous capsulesAmerican Journal of Obstetrics and Gynecology, 1969
- Acceptability of long-term contraceptive steroid administration in humans by subcutaneous Silastic capsulesAmerican Journal of Obstetrics and Gynecology, 1969
- Response of the nonpregnant uterus to vasopressin as an index of ovarian functionAmerican Journal of Obstetrics and Gynecology, 1968